GemPharmatech Co., Ltd. (SHA:688046)

China flag China · Delayed Price · Currency is CNY
24.15
+0.89 (3.83%)
At close: Jul 31, 2026
Market Cap9.88B +50.1%
Revenue (ttm)830.61M +18.6%
Net Income159.76M +44.8%
EPS0.40 +48.4%
Shares Out 408.97M
PE Ratio60.25
Forward PE50.31
Dividend0.22 (0.91%)
Ex-Dividend DateJun 9, 2026
Volume8,337,666
Open23.72
Previous Close23.26
Day's Range23.38 - 25.59
52-Week Range12.89 - 31.00
Beta0.86
Analystsn/a
Price Targetn/a
Earnings DateAug 20, 2026

About GemPharmatech

GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, knock-in mouse, point-mutation mouse, transgenic mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breed... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 1,590
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688046
Full Company Profile

Financial Performance

In 2025, GemPharmatech's revenue was 793.39 million, an increase of 15.51% compared to the previous year's 686.84 million. Earnings were 142.64 million, an increase of 29.88%.

Financial Statements